US court hands down Absorica claim construction

28-04-2015

A US court has ruled on how five claims in two patents related to acne drug Absorica (isotretinoin) should be construed, in a patent infringement case between Canada-based Cipher Pharmaceuticals and Actavis.


Markman hearing, Cipher, Actavis, Absorica, claim construction

LSIPR